Walleye Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$57.1K Sell
2024
Q4
$1.79M Buy
2024
Q3
$237K Buy
2024
Q2
$61K Buy
2024
Q1
Sell
2023
Q4
$147K Sell
2023
Q3
$216K Sell
2023
Q2
$1.85M Buy
2023
Q1
$1.81M Buy
2022
Q4
$143K Buy
2022
Q3
Hold
2022
Q2
Sell
2022
Q1
$1.05M Buy
2021
Q4
Sell
2021
Q3
$267 Buy
2021
Q1
Sell
2020
Q4
$765 Buy